Brice P C, Kelley A C, Butler P J
MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK.
Nucleic Acids Res. 1999 May 15;27(10):2080-5. doi: 10.1093/nar/27.10.2080.
Oligomerization of the Rev protein of human immuno-deficiency virus type 1 on its cognate response element is essential for export of the late viral mRNAs from the nucleus. Two regions of the protein, flanking the RNA binding site, have been defined as oligomerization sites after mutants (M4 and M7) had been reported to bind specifically to the response element but not to oligomerize in vivo or in vitro. These mutants are often used as paradigms for studies of Rev multimerization. We have re-examined the in vitro binding of these mutants to model Rev response elements, using improved gel mobility assays. We find that both mutants will form oligomers on the Rev response element, but have somewhat lower affinities for RNA than the wild-type protein. M7 has lower specific affinity, but shows little deficiency in oligomerization once binding starts. In contrast, M4 is multimerization deficient, as previously reported. Therefore, whilethe sites are correctly defined, it is inappropriate to employ the original M7 deletion mutant to study Rev oligomerization.
人类免疫缺陷病毒1型(HIV-1)的Rev蛋白在其同源反应元件上的寡聚化对于晚期病毒mRNA从细胞核输出至关重要。在有报道称突变体(M4和M7)能特异性结合反应元件,但在体内或体外均不能寡聚化之后,该蛋白位于RNA结合位点两侧的两个区域已被确定为寡聚化位点。这些突变体常被用作研究Rev多聚化的范例。我们使用改进的凝胶迁移率分析方法,重新检测了这些突变体与Rev反应元件模型的体外结合情况。我们发现这两种突变体都会在Rev反应元件上形成寡聚体,但与野生型蛋白相比,它们对RNA的亲和力略低。M7的特异性亲和力较低,但一旦开始结合,其寡聚化能力几乎没有缺陷。相比之下,正如之前报道的那样,M4存在多聚化缺陷。因此,虽然这些位点的定义是正确的,但使用原始的M7缺失突变体来研究Rev寡聚化是不合适的。